Genetic control of multiple sclerosis: Increased production of lymphotoxin and tumor necrosis factor‐α by HLA‐DR2+ T cells
- 1 November 1995
- journal article
- research article
- Published by Wiley in Annals of Neurology
- Vol. 38 (5) , 723-730
- https://doi.org/10.1002/ana.410380506
Abstract
Lymphotoxin (LT) and tumor necrosis factor‐α (TNF‐α) play an important role in the pathogenesis of multiple sclerosis (MS). MS is associated with the HLA‐DR2, Dw2, DQ6 HLA class II haplotype. Because both LT and TNF‐α are encoded in the HLA region, the HLA association of MS may be related to the production of these cytokines. To test this hypothesis, we investigated the production of LT, TNF‐α, and interferon‐γ (IFN‐γ) by CD4+ T‐cell lines (TCLs) specific for myelin basic protein (MBP) or tetanus toxoid (TT) isolated from MS patients and normal controls. After stimulation with specific antigen but not mitogen, TCLs from HLA‐DR2+ donors produced significantly more LT and TNF‐α, than TCLs from DR2− donors. In contrast, HLA‐DR2+ and DR2− TCLs did not differ in the production of IFN‐γ, a cytokine also produced by T cells but not encoded in the HLA region. Increased secretion of LT and TNF‐α was unrelated to the specificity (MBP vs TT), MHC restriction (HLA‐DR2 vs other DR molecules), or source (MS vs normal) of the TCLs. There was no significant association of the cytokine production with individual LT or TNF‐α alleles, indicating that the increased production of these cytokines may be linked to other polymorphic genes in this region. The results suggest that the association of MS with HLA‐DR2 implies a genetically determined propensity of T cells to produce increased amounts of LT and TNF‐α.Keywords
This publication has 49 references indexed in Scilit:
- TAP2 gene polymorphism contributes to genetic susceptibility to multiple sclerosisHuman Immunology, 1995
- The role of genetic factors in multiple sclerosis susceptibilityJournal of Neuroimmunology, 1994
- In healthy primates, circulating autoreactive T cells mediate autoimmune disease.Journal of Clinical Investigation, 1994
- TAP1 and TAP2 polymorphism in multiple sclerosis patientsHuman Immunology, 1994
- No independent association between a tumor necrosis factor‐α promotor region polymorphism and insulin‐dependent diabetes mellitusEuropean Journal of Immunology, 1993
- Map of the human MHCImmunology Today, 1993
- The Molecular Cell Biology of Interferon-gamma and its ReceptorAnnual Review of Immunology, 1993
- Immunological Aspects of Demyelinating DiseasesAnnual Review of Immunology, 1992
- Nonradioactive HLA class II typing using polymerase chain reaction and digoxigenin-11-2′-3′-dideoxyuridinetriphosphate-labeled oligonucleotide probesHuman Immunology, 1991
- Cellular immune reactivity within the CNSTrends in Neurosciences, 1986